In-Vitro Diagnostics (IVD) Market — By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics (PCR, Isothermal, NGS), Microbiology (Culture, ID/AST, Syndromic Panels), Hematology & Coagulation, Urinalysis and Others, Point-of-Care (Cross-Modality)), By Product (Reagents & Consumables, Instruments & Analyzers, Software & Services), By Application, End User, Test Setting, Sample Type, and Region — Forecast to 2030
                                 
                                 Category: Pharmaceuticals and Healthcare
                                 
                                 
                                 The global In-Vitro Diagnostics (IVD) market is a foundational pillar of modern healthcare, enabling clinicians to detect, monitor, and manage diseases using tests conducted on blood, urine, saliva, tissue, and other specimens. As of 2025, the IVD market is estimated to be worth approx USD 120 billion, with a forward-looking trajectory supported...